Status:

UNKNOWN

RISI in the Treatment of Recurrent Chest Wall Malignancies After EBRT

Lead Sponsor:

Peking University Third Hospital

Conditions:

Chest Wall Tumor

Eligibility:

All Genders

18-80 years

Brief Summary

This study will observe the efficacy and toxicities of 3-dimensional printing noncoplanar template assisted CT guided radioactive iodine-125 seeds implantation in the treatment of patients with recurr...

Detailed Description

Radioactive Iodine-125 seed brachytherapy is a conventional treatment in Peking University Third Hospital. Radioactive Iodine-125 seed brachytherapy is the implantation of Iodine-125 seed into tumors....

Eligibility Criteria

Inclusion

  • histological proven malignant tumor
  • tumor located in chest wall and lesion diameter \<= 10 cm
  • recurrence after external beam radiotherapy
  • there is no bleeding tendency
  • there are no serious or uncontrolled underlying diseases (such as severe or uncontrolled hypertension, diabetes, cardiovascular and cerebrovascular diseases, and/or organ dysfunction
  • there is an appropriate puncture path which is expected to achieve the treatment dose
  • KPS \> 70, which is expected to be able to tolerate puncture/ brachytherapy, and the expected survival time is longer than 3 months

Exclusion

  • there are skin ulceration, or with high risk of skin infection and ulceration
  • liquefaction and necrosis in a large area in tumor with poor expected seeds distribution
  • pregnant women, lactating women, psychiatric patients
  • patients with poor compliance can not complete the treatment
  • patients that researchers considered inappropriate to participate in this clinical trial

Key Trial Info

Start Date :

May 1 2020

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

April 30 2025

Estimated Enrollment :

30 Patients enrolled

Trial Details

Trial ID

NCT04077710

Start Date

May 1 2020

End Date

April 30 2025

Last Update

December 27 2023

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Peking University Third Hospital

Beijing, Beijing Municipality, China, 100191